[摘要]目的：观察加用丹红注射液治疗急性脑梗死（Acute cereb

[Abstract] Objective: To observe the safety and effectiveness of the treatment of acute cerebral infarct (ACI) with Danhong injection. Methods: 84 patients with ACI admitted to our hospital from January 2018 to November 2019 were randomly divided into a reference group and a treatment group, 42 cases in each. The reference group was treated with sodium ozagrel injection on the basis of conventional treatment. The treatment group was treated with Danhong injection on the basis of the reference group; the triglyceride (TG), total cholesterol (TC), and high-density lipoprotein C (HDL) were compared between the two groups -C) Three blood lipid index levels; compare the clinical effectiveness and the incidence of adverse reactions between the two groups. Results: Before treatment, the above two groups had no significant difference in blood lipid index (P> 0.05). After treatment, the reference group had no significant change in the above index levels (P> 0.05). The levels of TG and TC in the treatment group were significantly lower than before treatment. HDL-C level was significantly increased (P <0.05), compared with the reference group, the difference was statistically significant (both P <0.05); the clinical effective rate of the treatment group was significantly higher than that of the reference group (P <0.05); the two groups were bad The difference in reaction rate was not significant (P> 0.05). Conclusion: On the basis of ozagrel sodium injection combined with Danhong injection treatment, can significantly improve the blood lipid level of patients with ACI, improve clinical efficacy without increasing adverse reactions.

[摘要]目的：观察加用丹红注射液治疗急性脑梗死（Acute cerebral infarct，ACI）的安全性及有效性。方法：将2018年1月~2019年11月我院收治的84例ACI患者随机分为参照组与治疗组，各42例，参照组在常规治疗的基础上联合奥扎格雷钠注射液治疗，治疗组在参照组基础上加用丹红注射液治疗；比较两组三酰甘油（Triglyceride，TG）、总胆固醇（total cholesterol，TC）、高密度脂蛋白C（ High-density lipoprotein-C，HDL-C）三项血脂指标水平；比较两组临床有效率与不良反应发生率。结果：治疗前，两组上述血脂指标水平差异不显著（P＞0.05），治疗后，参照组上述指标水平无显著变化（P＞0.05），治疗组TG与TC水平均较治疗前显降低、HDL-C水平显著升高（P＜0.05），与参照组比较，差异均有统计学意义（均P＜0.05）；治疗组临床有效率显著高于参照组（P＜0.05）；两组不良反应发生率差异不显著（P＞0.05）。结论：在奥扎格雷钠注射液治疗的基础上联合丹红注射液治疗，可显著改善ACI患者血脂水平，提高临床疗效且不增加不良反应。

[Abstract] Objective: To observe the safety and efficacy of Danhong injection in the treatment of acute cerebral infarction (ACI). Methods: 84 patients with ACI admitted to our hospital from January 2018 to November 2019 were randomly divided into the reference group and the treatment group, 42 cases in each group. The reference group was treated with ozagrel sodium injection on the basis of conventional treatment, and the treatment group was treated with Danhong Injection on the basis of the reference group; the triglyceride (TG) and total cholesterol (total cholesterol) were compared between the two groups Cholesterol, TC and HDL-C were used to compare the clinical efficiency and the incidence of adverse reactions. Results: before treatment, there was no significant difference between the two groups (P > 0.05). After treatment, there was no significant difference between the two groups (P > 0.05) There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion: on the basis of ozagrel sodium injection combined with Danhong injection, it can significantly improve the blood lipid level of patients with ACI, improve the clinical efficacy and not increase adverse reactions.<br>